Ebola drug trial launches in Congo as death toll exceeds four thousand
A clinical trial testing an Ebola preventive drug has enrolled over 250 human participants in the Democratic Republic of the Congo as an active outbreak continues.
FTMQ Health, written by our newsroom1 view
A clinical trial for an Ebola drug has launched in the Democratic Republic of the Congo, as the death toll from the ongoing outbreak surpassed 4,000 people. Daily Sabah and Medical Xpress both report that the clinical trial aims to test a remedy designed to prevent individuals from contracting the Ebola virus. According to STAT News, health authorities recorded 4,018 deaths out of 8,300 documented cases, based on data released by the country's Health Ministry. [1][2][4]
Medical Xpress reported that the trial has enrolled more than 250 human participants to evaluate the intervention. STAT News noted that the outbreak was officially declared in eastern Congo on May 15. The outbreak has affected regions including Ituri Province, where health workers have gathered to request unpaid wages, and an Ebola treatment center in Bunia was recently burned down. [2][4]
Initial cases in the eastern Democratic Republic of the Congo were recorded on May 14 in Ituri Province, marking the country's 17th Ebola outbreak. It rapidly became the fastest-growing Ebola outbreak on record and the second largest overall. Ebola virus disease typically has an incubation period of 2 to 21 days, with early symptoms including high fever, muscle pain, and severe headache. [2][10][11]
Medical Xpress described the drug trial as a critical step in controlling the fastest-growing outbreak in the history of the disease. Health authorities in the Democratic Republic of the Congo continue efforts to suppress transmission as clinical evaluation of the protective drug progresses. [2][4]
In short
- More than 250 human participants have enrolled in an Ebola drug trial in Congo.
- Data from Congo's Health Ministry shows 4,018 deaths among 8,300 recorded cases.
- The outbreak was officially declared in eastern Congo in May 2026.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]Ebola drug trial launches in Congo as outbreak kills over 4,000Daily Sabah, 49d ago (the report this story comes from)
- [2]An Ebola treatment center was burned down as the death toll in Congo passes 4,000STAT News, 50d ago
- [3]Inside the study for a remedy to fight Congo's deadliest Ebola outbreakPBS, 48d ago
- [4]Inside the study for a remedy to fight Congo's deadliest Ebola outbreakMedical Xpress, 49d ago
- [5]Congo Ebola Clinical Trialkdhnews.com, 48d ago
- [6]More than 4,000 deaths recorded in DR Congo Ebola outbreakSky News, 50d ago
- [7]Ebola death toll surpasses 4,000 as DR Congo struggles to suppress outbreakAl Jazeera, 50d ago
- [8]Congo's Ebola outbreak has killed more than 4,000, government data showsReuters, 50d ago
- [9]More than 4,000 deaths recorded in DR Congo Ebola outbreak | ITV NewsITVX, 50d ago
Background
- [10]2026 Ebola epidemic on Wikipedia
- [11]Ebola on Grokipedia
Our newsroom writes these reports with the help of software, from the 11 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from FTMQ Health
Earlier reports of ours on the same people and subjects.
- Clinical trial begins in Congo to test preventive Ebola drugMedical Science, 48d ago
- First person receives trial vaccine for rare Ebola strainTop Stories, 24d ago
- British doctor infected with Ebola evacuated from DR Congo to London hospitalTop Stories, 15d ago
- Ebola outbreak in Democratic Republic of the Congo reaches eighth provincePublic Health, 32d ago
- Teleflex completes patient enrollment for European coronary scaffold studyMedical Science, 26d ago
More in Medical Science
- Study finds high co-infection rates among malaria patients in Peshawar16h ago
- Breast cancer drug trials expanded fivefold over 25 years study finds16h ago
- Current malaria criteria miss severe kidney injury risks in children1d ago
- CAR T cell therapy analysis reveals high inflammation but low mortality3d ago
- Diets rich in dairy and fruit linked to child height growth4d ago
- Meningococcal B vaccine prompts immune responses against gonorrhea in trial5d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.